Evaxion A (EVAX) EBITDA (2020 - 2026)
Evaxion A's (EVAX) quarterly EBITDA came in at -$4.2 million in Q1 2026, down 7.99% YoY from -$4.5 million in Q1 2025, and up 53.18% on a QoQ basis from -$8.9 million in Q4 2025.
Evaxion A (EVAX) EBITDA (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has 7 years of EBITDA data on file, last reported at -$4.2 million in Q1 2026.
- Quarterly EBITDA fell 7.99% year-over-year to -$4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.4 million (down 1.71% YoY) and the FY2025 annual result came in at -$9.2 million, up 37.32% from the prior year.
- EBITDA grew to -$4.2 million in Q1 2026, from -$8.9 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $3.0 million in Q3 2025 to a low of -$8.9 million in Q4 2025.
- A 5-year average of -$4.7 million and a median of -$4.6 million in 2024 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 272.85% in 2025, down 121.72% in 2025.
- Tracing EVAX's EBITDA over 5 years: stood at -$6.5 million in 2022, then soared by 33.12% to -$4.4 million in 2023, then climbed by 7.79% to -$4.0 million in 2024, then sank by 121.72% to -$8.9 million in 2025, then jumped by 53.18% to -$4.2 million in 2026.
- The last three EBITDA figures came in at -$4.2 million (Q1 2026), -$8.9 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Evaxion A | 26.86 Mn | 26.86 Mn | - | -4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | -8.92 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.53 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.26 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -7.72 Mn |
| Sep 30, 2021 | -18.11 Mn |
| Jun 30, 2021 | -12.20 Mn |